Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cardio Diagnostics Holdings (CDIOW) Other Operating Expenses (2021 - 2025)

Historic Other Operating Expenses for Cardio Diagnostics Holdings (CDIOW) over the last 5 years, with Q1 2025 value amounting to $87258.0.

  • Cardio Diagnostics Holdings' Other Operating Expenses rose 12262.53% to $87258.0 in Q1 2025 from the same period last year, while for Sep 2025 it was $312809.0, marking a year-over-year increase of 31842.88%. This contributed to the annual value of $202184.0 for FY2024, which is 1378.08% up from last year.
  • According to the latest figures from Q1 2025, Cardio Diagnostics Holdings' Other Operating Expenses is $87258.0, which was up 12262.53% from $225551.0 recorded in Q4 2024.
  • In the past 5 years, Cardio Diagnostics Holdings' Other Operating Expenses registered a high of $225551.0 during Q4 2024, and its lowest value of -$31102.0 during Q1 2022.
  • Over the past 5 years, Cardio Diagnostics Holdings' median Other Operating Expenses value was $26007.0 (recorded in 2021), while the average stood at $33459.0.
  • Over the last 5 years, Cardio Diagnostics Holdings' Other Operating Expenses had its largest YoY gain of 272510.4% in 2022, and its largest YoY loss of 620277.08% in 2022.
  • Over the past 5 years, Cardio Diagnostics Holdings' Other Operating Expenses (Quarter) stood at $20887.0 in 2021, then soared by 49.03% to $31127.0 in 2022, then skyrocketed by 54.5% to $48090.0 in 2023, then surged by 369.02% to $225551.0 in 2024, then tumbled by 61.31% to $87258.0 in 2025.
  • Its Other Operating Expenses was $87258.0 in Q1 2025, compared to $225551.0 in Q4 2024 and -$5247.0 in Q3 2024.